Patents by Inventor Colleen M. SYNAN

Colleen M. SYNAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11738002
    Abstract: The present disclosure relates to methods of treating neurological or psychiatric diseases or disorders, such as schizophrenia. Compound 1, or a pharmaceutically acceptable salt thereof, is an antipsychotic agent with a non-D2 mechanism of action. Adverse events associated with antipsychotic agents that target the D2 dopamine receptor can be reduced by treating disorders with Compound 1, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: August 29, 2023
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Carrie A. Bowen, Seth Cabot Hopkins, Colleen M. Synan
  • Publication number: 20210315859
    Abstract: The present disclosure relates to methods of treating neurological or psychiatric diseases or disorders, such as schizophrenia. Compound 1, or a pharmaceutically acceptable salt thereof, is an antipsychotic agent with a non-D2 mechanism of action. Adverse events associated with antipsychotic agents that target the D2 dopamine receptor can be reduced by treating disorders with Compound 1, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Inventors: Carrie A. BOWEN, Seth Cabot HOPKINS, Colleen M. SYNAN